2 Compelling Reasons to Buy This Reawakened Pharma Giant
At the end of March, The Journal of the American Medical Association released a detailed summary of the leading causes of death in the U.S. from 2015 to 2020. Heart disease is No. 2 on that list. Type 2 diabetes, which can raise the risk of heart failure, came in at No. 9.
The effort to reduce deaths related to these causes continues within the healthcare industry, thanks to companies like Eli Lilly (NYSE: LLY). Now, Lilly is on the verge of introducing a new contender to join that fight.
Image source: Getty Images.
Source Fool.com
